The NICE Diagnostics Assessment Programme

Health Policy and Technology

Volumn 1, Issue 1, 2012, Pages 5-7

  Crabb, Nick ^a   Marlow, Mirella ^a   Bell, Hanan ^a   Newland, Adrian ^a  

^a NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTICS ASSESSMENT PROGRAMME; DRUG INDUSTRY; HEALTH PROGRAM; HUMAN; MEDICAL ASSESSMENT; MEDICAL TECHNOLOGY; MOLECULAR DIAGNOSIS; TREATMENT OUTCOME;

EID: 84861145416     PISSN: 22118837     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlpt.2012.01.005     Document Type: Article

References (0)